Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Stem Cells Used to Generate Functional Arterial Endothelial Cells

By LabMedica International staff writers
Posted on 20 Jul 2017
A team of cardiovascular disease researchers developed a method for using human pluripotent stem cells to generate fully functional arterial endothelial cells, which are vital for vascular development and disease research.

Currently, arterial endothelial cells that have been derived from human pluripotent stem cells have not been of clinical value as they have lacked the range of arterial-specific functions in vitro and the protective function for ischemic tissues in vivo.

To advance the production of functional arterial cells, investigators at the University of Wisconsin's Morgridge Institute for Research (Madison, USA) combined single-cell RNA sequencing and CRISPR-Cas9 technology to identify pathways for regulating arterial endothelial cell differentiation. More...
They then manipulated these pathways and generated arterial endothelial cells that demonstrated unprecedented arterial-specific functions as well as improved survival of myocardial infarction.

Single-cell RNA sequencing identified the signaling pathways - involving 40 genes of optimal relevance - critical for arterial endothelial cell differentiation. CRISPR-Cas9 gene editing technology allowed the creation of reporter cell lines to monitor arterial differentiation in real time.

The investigators reported in the July 10, 2017, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences that by using these protocols they were able to produce endothelial cells from multiple human embryonic and induced pluripotent stem cell lines with gene expression profiles, oxygen consumption rates, nitric oxide production levels, shear stress responses, and TNFalpha-induced leukocyte adhesion rates characteristic of arterial endothelial cells.

"Our ultimate goal is to apply this improved cell derivation process to the formation of functional arteries that can be used in cardiovascular surgery," said senior author Dr. James Thomson, professor of cell and regenerative biology at the Morgridge Institute for Research. "This work provides valuable proof that we can eventually get a reliable source for functional arterial endothelial cells and make arteries that perform and behave like the real thing."

Related Links:
Morgridge Institute for Research


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.